AGG Talks: Government Insight for Life Sciences Leaders Podcast Series
Our podcast series hosts strategic conversations at the center of life sciences, law, and policy. During each episode, AGG’s former government attorneys bring firsthand knowledge and updates from their respective agencies — such as the HHS and DOJ — and examine how the latest regulatory developments and enforcement trends impact life sciences organizations. These insider insights, paired with the practical experience of AGG’s Life Sciences team, offer the life sciences industry a map of the road ahead in today’s regulatory environment.
Episodes
10 episodes
HHS Policy Changes, Supreme Court Rulings, and the DOJ-HHS False Claims Act Working Group
In this episode, Alan Minsk, AGG Food & Drug practice chair and Life Sciences co-chair, and Brian Stimson, co-chair o...
•
Season 2
•
Episode 1
•
13:16
Tell Me Lies, Tell Me Sweet Little Lies: FDA Is Not My Only Potential Headache When It Comes to Product Promotion
In this episode,
•
Season 1
•
Episode 9
•
29:29
Business Divorces in the Food and Supplements Space
In this episode, Michael E. Burke, partner and co-chair of the Pharmaceutical & Biotechnology industry team is joined by
•
Season 1
•
Episode 8
•
23:13
Fee Waivers for Small Businesses: Who Qualifies for the Small Business User Fee Waiver for Drugs and Biologics and How to Apply from an FDA and Corporate Perspective
In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and Genevieve M. Razick, an attorney in our Healthc...
•
12:31
Data Privacy Issues Life Sciences Companies May Encounter
In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and co-chair of AGG’s Data Privacy practice, Kevin L. Coy,...
•
Season 1
•
Episode 6
•
19:47
FDA Regulation of Rx Drug and Medical Device Advertising and Promotion: 2020 Year in Review
In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and team member, Genevieve M. Razick, give an overview of FDA’s Office of Prescription Drug...
•
Season 1
•
Episode 5
•
20:31
FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment
In this episode, partner Kevin M. Bell and of counsel Bob Durkin discuss some of the more interesting issues and challeng...
•
Season 1
•
Episode 4
•
39:58
Pandemic Marketing 101: Do’s and Don’ts to Market Your Brands, Products, and Services Safely
In this episode, partner Anuj Desai and of counsel Carolina M. Wirth discuss the Federal Trade Commission (FTC) and Fo...
•
Season 1
•
Episode 3
•
28:51